DEC 20, 2019
Protocol T Extension Results
Retina Subday 2019
Macular Disease, Retina/Vitreous
In this presentation from Retina Subday 2019, Dr. John Wells discusses the DRCR Retina Network's 5 year outcomes after aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.